3. Umbruch 4.4..2005 - Online Pot

Cannabinoids and anxiety 147
effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur J
Neurosci 17: 1279–1286
14 Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G,
Calignano A et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat
Med 9: 76–81
15 Consroe P, Musty RE, Tillery W, Pertwee R (1997) Perceived effects of cannabis smoking in
patients with multiple sclerosis. European Neurology 38: 44–48
16 Consroe P, Tillery W, Rein J, Musty RE (1998) Reported marijuana effects in patients with spinal
cord injury. 1998 Symposium on the Cannabinoids, Burlington, VT: International Cannabinoid
Research Society, 64
17 Musty RE (1988) Individual differences as predictors of marihuana phenomenology. In: G
Chesher, P Consroe, RE Musty (eds): Marihuana: An International Research Report. Australian
Government Publishing Service, Canberra, 201–207
18 Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and
other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berl) 76:
245–250
19 Zuardi AW, Cosme RA, Graeff FG, and Guimaraes FS (1993) Effects of ipsapirone and cannabidiol
on human experimental anxiety. J Psychopharmacol 7: 82–88
20 Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques
PM, Hallak JE, McGuire PK, Filho Busatto G (2004) Effects of cannabidiol (CBD) on regional
cerebral blood flow. Neuropsychopharmacology 29: 417–426